Fibroblast-IL-7 feedback drives PDPN + monocytes to restrain CD4 + T cell responses

Read full text Summarise with VIRAT
Authors: Yan Fu, Christophe Toussaint, Ina Sauerland, Elisabeth Reiß, Lars Philipsen, Patricia Gintschel, Laura Knop, Andreas Dominik Braun, Bastian Kruse, Leon-Alexander Dewitz, Jonas Amore, Vladyslava Dovhan
+21 more Sönke Weinert, Nouria Jantz-Naeem, Iris Baars, Juliane Mohr, Julia Christin Prein, Cora Schwendele, Philipp Bruno, Martin Böttcher, Nicole Gröger, Hannah Van Hove, Melanie Greter, Burkhard Becher, Sascha Kahlfuß, Burkhart L. Schraven, Robert Geffers, Thomas Tüting, Nicole Joller, Stephan Fricke, Antoine‐Emmanuel Saliba, Thomas Schüler, Andreas J. Müller
Cited by: 0
References: 112

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Summary During immune responses, pro-and anti-inflammatory mechanisms must be balanced to ensure pathogen clearance while limiting tissue damage. Monocyte-derived cells contribute to both processes, yet the underlying regulatory circuits remain incompletely defined. Here, we show that a subset of PDPN + IL-7R + monocyte-derived cells that impair effector CD4 ⁺ T cell–mediated control of intracellular pathogens, and thus perpetuate the infection. Fibroblast-derived IL-7 drives this immunosuppressive program, which is up-regulated in response to IFNγ. We thus uncover a cytokine-dependent feedback circuit in which elevated IFNγ induces IL-7 production by fibroblasts, licensing immunosuppressive monocyte-derived cells that restrain CD4⁺ T cell responses. This mechanism links excessive inflammation to immune suppression at the expense of pathogen control. Targeting this feedback loop may enable therapeutic strategies that enhance antimicrobial immunity while preserving tissue integrity.

Fields of Study & Subjects

T-cell and B-cell Immunology Immune cells in cancer Immune Response and Inflammation

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publication date
26 March 2026
Language
EN
Document type
Preprint